CLDX : Analysis & Opinions

  1. 2 Biotechs to Keep an Eye On

    June 23, 2011
    There's a new way of treating cancer and these two companies are leading the pack, notes Michael Murphy of New World Investor. ...
  2. Pfizer's Decision Leaves Celldex Reeling

    September 7, 2010
    We'll look at what Pfizer withdraw of support for Celldex's cancer vaccine means for the biotech's stock.
  3. Cancer Vaccines Continue To Show Promise

    July 7, 2010
    Dendreon has put cancer vaccines back in the spotlight, but can they live up to their hype?
Trading Center